Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients
-
- André Tichelli
- Hematology, University Hospital, Basel, Switzerland
-
- Eric Beohou
- EBMT Paris Study Office/CEREST-TC, Hôpital Saint Antoine, Paris, France
-
- Myriam Labopin
- EBMT Paris Study Office/CEREST-TC, Hôpital Saint Antoine, Paris, France
-
- Gérard Socié
- Department of Hematology–BMT, Hôpital St Louis, Paris, France
-
- Alicia Rovó
- Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
-
- Manuela Badoglio
- EBMT Paris Study Office/CEREST-TC, Hôpital Saint Antoine, Paris, France
-
- Anja van Biezen
- EBMT Data Office Leiden, Leiden University Medical Center, Leiden, the Netherlands
-
- Peter Bader
- Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, Frankfurt, Germany
-
- Rafael F. Duarte
- Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain
-
- Grzegorz Basak
- Department of Hematology, Oncology and Internal Medicine, Central Clinical Hospital, the Medical University of Warsaw, Warsaw, Poland
-
- Nina Salooja
- Center for Haematology, Imperial College, London, United Kingdom
収録刊行物
-
- JAMA Oncology
-
JAMA Oncology 5 (2), 229-, 2019-02-01
American Medical Association (AMA)